OSE Immunotherapeutics SA (EPA:OSE)
3.022
-0.052 (-1.69%)
Apr 24, 2026, 4:54 PM CET
Revenue by Segment
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.